← FDA DRUG APPROVALS

FDA ANDA · ANDA077142

METHADONE HYDROCHLORIDE

Sponsor: SPECGX LLC

APPLICATION
ANDA077142
TYPE
ANDA
ORIGINAL APPROVAL
2005-07-12
LATEST ACTION
2018-09-18
ROUTE
ORAL
DOSAGE FORM
TABLET, FOR SUSPENSION
MARKETING STATUS
Prescription

Products

METHADONE HYDROCHLORIDEPrescription
METHADONE HYDROCHLORIDE 40MG · TABLET, FOR SUSPENSION · ORAL

Approval history

2018-09-18REMS · Supplement 17AP
2014-12-13Labeling · Supplement 11 · standardAP
2014-11-05Manufacturing (CMC) · Supplement 8AP
2009-11-09Labeling · Supplement 6AP
2007-04-04Labeling · Supplement 5AP
2006-09-20Labeling · Supplement 2AP
2006-03-23Labeling · Supplement 3AP
2005-07-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →